Rab Prinjha, Head at GSK to speak at 2nd Epigenetics Conference May 30-31, 2012 Boston
Rab Prinjha, Interim Head of Epinova Epigenetics DPU and Head of Biology at GlaxoSmithKline will give a featured presentation on "Epigenetic Modification in the Treatment of Immunoinflammatory Diseases" at the 2nd Epigenetics in Drug Discovery Conference taking place on May 30-31, 2012 in Boston, MA.
- Boston, MA-NH (1888PressRelease) April 09, 2012 - Dr. Prinjha joined GlaxoSmithKline as Director of External Drug Discovery in 1997, focusing on their business development opportunities, review approval and management of drug discovery alliances. In 2010, he became Head of Target Progression at GSK and worked on the identification of novel epigenetic targets for immuno-inflammation drug discovery and generation of biological rationale for target progression through the portfolio (target identification to FTIH). In January 2012, Dr. Prinjha became Interim Head of Epinova Epigenetics DPU and Head of Biology at GSK.
GTC's 2nd Epigenetics in Drug Discovery conference is the only epigenetics conference that brings together a balanced mix of leading experts from the industry and academia to collaborate on the latest cutting edge research on novel mechanisms, therapeutics, technologies and diagnostics for epigenetics drug discovery. Some key discussions around epigenetics drug discovery at the conference include:
- The role of epigenetics in human diseases such as cancer, leukaemia, neurodegenerative conditions, neuropsychiatric disorders, inflammation, etc.
- Cutting edge research from GlaxoSmithKline, Epizyme, Genentech, Constellation, Cellzome, RaNA Therapeutics, Pfizer, Harvard, Massachusetts Institute of Technology, etc.
The conference is part of the Omics Evolution Summit, which includes 6 co-located conferences. Register for the entire summit and have access to the all of the following conferences:
2nd Genomic & Proteomic Drug Discovery Conference
3rd RNAi Research and Development Conference
7th Protein Kinases in Drug Discovery Conference
2nd Next Generation Sequencing Conference
Genome-wide Partnering and Deal Making Conference
Sign up for the pre-summit workshop on Clinical Sequencing on May 29th. This interactive workshop is dedicated to discussing emerging technologies, current and future trends of clinical sequencing, and the implementation of next generation sequencing in a CLIA environment.
For more information, please visit www.gtcbio.com
Event Website:
http://www.gtcbio.com/index.php?option=com_conference&file=program&cn=2nd%20Epigenetics%20in%20Drug%20Discovery&cid=82
###
space
space
Satisfied Users & 
Approved Press Releases
Print
Email
Report Spam